Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dose-Response Study of Linear Asymmetric rTMS in Adolescent Treatment-Resistant Depression: Tolerability of Treatment Durations Ranging From Ten Days to One Day

NCT03986658 is registered in ClinicalTrials.gov with NeuroQore Inc. as lead sponsor.

NCT NCT03986658
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03986658 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dose-Response Study of Linear Asymmetric rTMS in Adolescent Treatment-Resistant Depression: Tolerability of Treatment Durations Ranging From Ten Days to One Day
Lead sponsor
NeuroQore Inc.
Phase
Not applicable
Overall status
Unknown status
Start date
March 31, 2022
Completion date
December 31, 2022
Enrollment
19 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

treatment resistant depression